Morphologic Features Which Affect Validation And Proficiency Test Performance Of BiopsyProven HSIL Pap Tests. The ASCP GYN PT & Assessment Committee
|
|
- Stephany Porter
- 5 years ago
- Views:
Transcription
1 Morphologic Features Which Affect Validation And Proficiency Test Performance Of BiopsyProven HSIL Pap Tests The ASCP GYN PT & Assessment Committee
2 The ASCP GYN PT & Assessment Committee Robert A. Goulart, MD, Chair Jamie L. Covell, BS, CT(ASCP), Vice-chair Thomas A. Bonfiglio, MD Mark H. Stoler, MD William J. Frable, MD Carol M. Filomena, MD Syed Ali, MD Judith L. Burns, CT(ASCP) Mark Dieterich, MD Ronald D. Luff, MD, MPH Donna K. Russell, MS, CT(ASCP), HT, CMIAC Alia Salhadar, MD Maria A. Friedlander, MPA, CT(ASCP) Raja M. Gidwani, MD (Fellow Member) Enid Boeding, MD (Resident Member) Rhonda L. Metzler, SCT(ASCP), Senior Manager
3 Conflicts of Interest The Authors Have No Conflicts of Interest to Disclose.
4 Introduction Before Pap tests are entered into the American Society for Clinical Pathology (ASCP) GYN Proficiency Test (PT) program: 100% target diagnosis agreement amongst 5 committee (3 MD, 2 CT) referee reviewers Minimum performance of 90% target diagnosis agreement after 40 individual reads (validation) Biopsy confirmation (SIL and cancer cases)
5 Introduction Despite this vigorous process, a small subset of validated slides does not perform as well in actual testing.
6 Introduction When the target diagnosis agreement for any slide level falls below 90%: Immediately removed from the pool of active test slides Similarly, a small subset of slides is removed late in the validation process (between reads) What can we learn from the morphologic features of these cases?
7 Introduction Comparison of the morphologic features of "high" vs. "low" performing slides could provide information concerning subtle differences that result in less reproducible interpretations: Target diagnostic category of HSIL Both clinically significant and relatively common Inter-cytopathologist HSIL diagnostic agreement relatively poor (Diagn Cytopathol 16(1):87, 1997)
8 Conventional Pap Studies Features associated with Conventional Pap smear discrepancies in biopsy-proven CIN II/III cases in PT (Arch Pathol Lab Med 129(6):733, 2005): Fewer dysplastic cells (less than 50) Lack of large dysplastic cells Lack of keratinization Hypochromasia (not correlated with performance) Non-PT Conventional Pap studies: Processing artifacts (air-drying) Excessive blood/obscuring inflammation Sampling/rare abnormal cells
9 Liquid-Based Pap Studies Features associated with ThinPrep Pap test discrepancies in biopsy-proven CIN II/III cases in PT (Arch Pathol Lab Med 128(7):746, 2004): Fewer dysplastic cells (less than 250) Non-PT ThinPrep Pap tests (Hong Kong Med J 14(4):292, 2008): Fewer abnormal cells Fewer cells with koilocytic change Less pronounced hyperchromasia
10 Materials and Methods Two HSIL ThinPrep Pap test groups Each 30 cases (slides) High performers (HP): 90% target diagnosis agreement throughout the validation process and during active testing Low performers (LP): failed validation or were soon removed from the active test pool
11 Materials and Methods Two HSIL ThinPrep Pap test groups Each slide was re-evaluated by five committee reviewers in a blinded fashion Slides were also reviewed for overall technical quality Staining (fading)
12 Materials and Methods Review characteristics: Predominant HSIL cell pattern (groups vs. single cells) Cell groups (< or > 10) Single HSIL cells (< or > 20) Relative number of LSIL cells Nuclear membrane irregularity Hyperchromasia Nuclear chromatin granularity (coarse vs. fine) Nucleoli (present/absent in majority of HSIL cells) N/C ratio Atrophy Atypical keratinized squamous cells Inflammation Organisms (Trichomonas and Candida) Endometrial cells
13 Materials and Methods Review characteristics: Reviewers instructed to note which slides they perceived might perform poorly A consensus interpretation (majority) was assigned for each category Statistical evaluation (Fisher s exact test)
14 Materials and Methods Predominant HSIL Cell Pattern
15 Materials and Methods Nucleoli Present
16 Results 59/60 slides were considered technically satisfactory Single slide within the LP group deemed technically unsatisfactory due to stain fading
17 Results Review characteristics: Predominant HSIL cell pattern (groups vs. single cells) Cell groups (< or > 10) Single HSIL cells (< or > 20) Relative number of LSIL cells Nuclear membrane irregularity Hyperchromasia Nuclear chromatin granularity (coarse vs. fine) Nucleoli (present/absent in majority of HSIL cells) N/C ratio Atrophy Atypical keratinized squamous cells Inflammation Organisms (Trichomonas and Candida) Endometrial cells
18 Results Review characteristics: Predominant HSIL cell pattern (groups vs. single cells) Cell groups (< or > 10) Single HSIL cells (< or > 20) Relative number of LSIL cells Nuclear membrane irregularity Hyperchromasia Nuclear chromatin granularity (coarse vs. fine) Nucleoli (present/absent in majority of HSIL cells) N/C ratio Atrophy Atypical keratinized squamous cells Inflammation Organisms (Trichomonas and Candida) Endometrial cells
19 Results Statistically significant difference in criteria Number of cell groups (>/= 10) Number of single cells (>/= 20) Presence of nucleoli All associated with the Good Performer subset of cases Prediction of slide performance
20 Conclusions An increased quantity of HSIL cells, either in cell groups or as single cells, correlated with completion of the validation process and high field PT performance (reproducibility of HSIL target diagnosis). A high level of performance was also seen in the slides with nucleoli present in the majority of HSIL cells, albeit an infrequent finding.
21 Conclusions Although only one-half of the 30 low performing cases could be predicted by the reviewers, designation as such was highly accurate.
22 Conclusions Clinical Correlates In routine Pap test sign-out, attention to cases with rare potential HSIL cells (both in single cells and cell groups), particularly if nucleoli are present, should increase sensitivity for detection of CIN II/III. Further supporting evidence of ASC-H Stresses importance of locator skills
23 Thank you The ASCP GYN PT & Assessment Committee
Evaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions on Cervical Smear
The Korean Journal of Pathology 2010; 44: 528-35 DOI: 10.4132/KoreanJPathol.2010.44.5.528 Evaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions
More informationHyperchromatic Crowded Groups: What is Your Diagnosis? Session 3000
Hyperchromatic Crowded Groups: What is Your Diagnosis? Session 3000 Thomas A. Bonfiglio, M.D. Professor Emeritus, Pathology and Laboratory Medicine University of Rochester Disclosures In the past 12 months,
More informationSQUAMOUS CELLS: Atypical squamous cells (ASC) - of undetermined significance (ASC-US) - cannot exclude HSIL (ASC-H)
SQUAMOUS CELLS: Atypical squamous cells (ASC) - of undetermined significance (ASC-US) - cannot exclude HSIL (ASC-H) ASC refers to cytologic changes suggestive of SIL, which are qualitativley or quantitatively
More informationCytology Report Format
Squamous Precursor Lesions and Malignancies In Pap Test Dina R. Mody, MD, FCAP Director of Cytology The Methodist Hospital, Houston, TX Professor of Pathology and Laboratory Medicine Weill Medical College
More informationNILM Pap Slides From Women 30 Years of Age and Older With Positive High-Risk HPV DNA
NILM Pap Slides From Women 30 Years of Age and Older With Positive High-Risk HPV DNA Focused Rescreening Prior to Report Issuance, An Enhanced Quality Control Measure Karen Cormier, CT(ASCP), 1 Michael
More informationMorphology I Slide: 1
Morphology I Slide: 1 Morphology I Slide: 2 ThinPrep Morphology Normal Cytology Morphology I Slide: 3 CT & Pathologist Training Training program begins with ThinPrep morphology presentation Microscopic
More informationPrepared By Jocelyn Palao and Layla Faqih
Prepared By Jocelyn Palao and Layla Faqih The structure of the suspected atypical cell should always be compared to the structure of other similar, benign, cells which are present in the smears. The diagnosis
More informationThe diagnostic category of atypical squamous cells of undetermined
100 CANCER CYTOPATHOLOGY Significance of a Diagnosis of Atypical Squamous Cells of Undetermined Significance for Papanicolaou Smears in Perimenopausal and Postmenopausal Women Jeffrey T. Keating, M.D.
More informationNew Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology
New Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology United States and Canadian Academy of Pathology 102 nd Annual Meeting Baltimore, Maryland Christina S. Kong, M.D.
More informationLessons From Cases of Screened Women Who Developed Cervical Carcinoma
Lessons From Cases of Screened Women Who Developed Cervical Carcinoma R. Marshall Austin MD,PhD Magee-Womens Hospital of University of Pittsburgh Medical Center raustin@magee.edu Why Focus Study On Cases
More informationCINtec p16 INK4a Staining Atlas
CINtec p16 INK4a Staining Atlas Rating Rating Positive The rating positive will be assigned if the p16 INK4a -stained slide shows a continuous staining of cells of the basal and parabasal cell layers of
More informationClinical Practice Guidelines June 2013
Clinical Practice Guidelines June 2013 General Principles: The Papanicolaou (Pap) smear is widely credited with reducing mortality from cervical cancer, and remains the single best method for the early
More informationLGM International, Inc.
Liqui-PREP TM Cytology Atlas Preface The following pictures are examples with descriptions of cytology slides processed with the Liqui-PREP TM System.. The descriptions are reviewed by Pathologists. It
More informationHistopathology: Cervical HPV and neoplasia
Histopathology: Cervical HPV and neoplasia These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about
More informationGYN (Glandulars) Still Difficult After All These Years! Dina R Mody, MD Director of Cytology Laboratories and fellowship Program Methodist Hospital
GYN (Glandulars) Still Difficult After All These Years! Dina R Mody, MD Director of Cytology Laboratories and fellowship Program Methodist Hospital and Bioreference Labs (Houston) Department of Pathology
More informationThe ABCs of TBS. A Novice's Guide to the Bethesda System
CE U P D A T E W O M E N ' S HEALTH III Julia Woodruff Wildes, MD The ABCs of TBS A Novice's Guide to the Bethesda System This is the third and final article in a three-part series on women's health. The
More informationCase 3 - GYN. History: 66 year old, routine Pap test. Dr. Stelow
Case 3 - GYN History: 66 year old, routine Pap test Dr. Stelow Case 3 66 year year old woman Routine Pap Test Cytologic Features 3 dimensional clusters of cells with small to moderate amount of
More informationWorkshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation
Workshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation May Yu Director of Cytology Laboratory Service Department of Anatomical & Cellular Pathology Prince of Wales Hospital Cervical
More informationWelcome. THE ROLE OF oncofish cervical ASSESSMENT OF CERVICAL DYSPLASIA. March 26, 2013
THE ROLE OF oncofish cervical IN THE ASSESSMENT OF CERVICAL DYSPLASIA The phone lines will open, 15 minutes prior to the start of the webinar. Toll Free: 1-800-867-0864. Entry Code: 83956484. You may download
More informationEU guidelines for reporting gynaecological cytology
EU guidelines for reporting gynaecological cytology Amanda Herbert Guy s & St Thomas Foundation NHS Trust 5th EFCS Annual Tutorial, Trondheim, Norway 28 th May 1 st June 2012 EU guidelines aim to harmonize
More informationChapter 10: Pap Test Results
Chapter 10: Pap Test Results On completion of this section, the learner will be able to: 1. Identify how Pap test results are interpreted and the reasons for normal and abnormal results. 2. Describe the
More informationCytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.
Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches. Fadi W. Abdul-Karim MD MEd. Professor of Pathology. Vice chair for education. Robert Tomsich Pathology and Lab Med
More informationPAP. Interlaboratory Comparison Program in Cervicovaginal Cytopathology (PAP) YEAR END SUMMARY REPORT. Anatomic Pathology Programs
2005 PAP Interlaboratory Comparison Program in Cervicovaginal Cytopathology (PAP) Surveys and Educational Anatomic Pathology Programs YEAR END SUMMARY REPORT 2005 College of American Pathologists. The
More informationCervical cytology screening has led to a reduction in cancer mortality
CANCER CYTOPATHOLOGY 105 ThinPrep Pap Test Performance and Biopsy Follow-Up in a University Hospital A. Betts Carpenter, M.D., Ph.D. Diane D. Davey, M.D. Department of Pathology and Laboratory Medicine,
More informationTable of Contents. 1. Overview. 2. Interpretation Guide. 3. Staining Gallery Cases Negative for CINtec PLUS
Staining Atlas Table of Contents 1. Overview 1.1 Introduction 1.2 Role of p16 INK4a 1.3 Role of Ki-67 1.4 Molecular Pathogenesis 1.5 p16 INK4a Expression in Cervical Dysplasia 1.6 The Concept of CINtec
More information1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal
Diseases of cervix I. Inflammations 1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal squamous mucosa
More informationEffectiveness of the ThinPrep Imaging System:
Effectiveness of the ThinPrep Imaging System: Clinical Experience in a Low Risk Screening Population Jacalyn L. Papillo, B.S., C.T., A.S.C.P., 1 * Timothy L. St. John, B.S., C.T., A.S.C.P., 1 and Gladwyn
More informationPAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals
PAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals Historical Named after George Papanicolaou, a Greek American Studied cervical epithelium in menstrual cycle of guinea
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Cytodiagnostic Study of Cervical Lesions Using the Bethesda System with Histopathological Tahera
More informationCAP Laboratory Improvement Programs
CAP Laboratory Improvement Programs Comparison of Performance of Conventional and ThinPrep Gynecologic Preparations in the College of American Pathologists Gynecologic Cytology Program Andrew A. Renshaw,
More informationAgreement Between Cytotechnologists and Cytopathologists as a New Measure of Cytopathologist Performance in Gynecologic Cytology
Agreement Between Cytotechnologists and Cytopathologists as a New Measure of Cytopathologist Performance in Gynecologic Cytology Andrew M. Quinn, MD 1 ; Abu T. Minhajuddin, PhD 2 ; Linda S. Hynan, PhD
More informationComparative Features of Ductal Carcinoma In Situ and Infiltrating Ductal Carcinoma of the Breast on Fine-Needle Aspiration Biopsy
Comparative Features of In Situ and of the Breast on Fine-Needle Aspiration Biopsy HELEN H. WANG, M.D., DR. P.H., BARBARA S. DUCATMAN, M.D., AND DAWN EICK, CT(ASCP) To evaluate the usefulness of fine-needle
More informationACGME Competency / Milestone Assessment. The Pap Test. Ricardo R. Lastra, MD Zubair W. Baloch, MD, PhD
1 ACGME Competency / Milestone Assessment The Pap Test Ricardo R. Lastra, MD Zubair W. Baloch, MD, PhD Department of Pathology & Laboratory Medicine University of Pennsylvania, Perelman School of Medicine
More informationCytyc Corporation - Case Presentation Archive - July 2002
ThinPrep Pap Test History: 34 Year Old Female LMP: Day 20 Specimen Type: Cervical/Vaginal Case provided by Mark Tulecke, M.D. and Gabrielle Trawinski CT (ASCP), Mount Auburn Hospital, Cambridge, Massachusetts.
More informationCervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013
Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines General Principles: Since its introduction in 1943, Papanicolaou (Pap) smear is widely
More informationHPV: cytology and molecular testing
HPV: cytology and molecular testing Human Papillomavirus and how we test for it at Medlab Central Palmerston North for Cervical Cancer prevention and management. Developed by Reem Mustafa Cytology and
More informationAcceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index
DOI 10.1007/s00404-012-2569-y GYNECOLOGIC ONCOLOGY Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index Hadi Shojaei Fariba Yarandi Leila
More informationAward Top Quizzes For Residents
Award Top Quizzes For Residents Giovanni Negri, MD, Bolzano (Italy) Eva M. Wojcik MD, Department of Pathology, Loyola University, Chicago (USA) Esther D. Rossi MD, PhD, MIAC, Division of Anatomic Pathology
More informationCervical Cytology Preparations
GYN Cytology Cervical Cytology Preparations CS TP SP Fadi W. Abdul-Karim, MD MSMedu Department of Anatomic Pathology Vice Chair Education Professor of Pathology Cleveland Clinic Cleveland Ohio Conventional
More informationObjectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells
2013 California Society of Pathologists 66 th Annual Meeting San Francisco, CA Atypical Glandular Cells to Early Invasive Adenocarcinoma: Cervical Cytology and Histology Christina S. Kong, MD Associate
More informationCME/SAM. High-Risk HPV Testing in Women 30 Years or Older With Negative Papanicolaou Tests Initial Clinical Experience With 18-Month Follow-up
Anatomic Pathology / HPV Testing in Negative Papanicolaou Tests High-Risk HPV Testing in Women 30 Years or Older With Negative Papanicolaou Tests Initial Clinical Experience With 18-Month Follow-up Michael
More informationHPV Testing & Cervical Cancer Screening:
HPV Testing & Cervical Cancer Screening: Are they linked? By William Chapman, MD, FRCPC Screening for precursor lesions of cervical cancer by the Papanicolaou (Pap) smear has been one of the greatest success
More informationThe Korean Journal of Cytopathology 13(1): 14-20, 2002
13 1 The Korean Journal of Cytopathology 13(1): 14-20, 2002 : ASCUS 1941 Papanicolaou. The Bethesda System(TBS) 1) 1988, atypical squamous cells of undetermined significance(ascus), low-grade squamous
More informationMaturation Index 3/29/2017. Disclosure of Relevant Financial Relationships. Gynecologic Cytology. Normal Maturation of Squamous Epithelium : :
Gynecologic Cytology Fadi W. Abdul Karim, MD MEd Department of Anatomic Pathology Vice Chair Education RT PLMI Professor of Pathology Cleveland Clinic. Cleveland Ohio Disclosure of Relevant Financial Relationships
More informationCase Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure
Disclosure Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Associate Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics This
More informationSESSION J4. What's Next? Managing Abnormal PAPs in 2014
37th Annual Advanced Practice in Primary and Acute Care Conference: October 9-11, 2014 2:45 SESSION J4 What's Next? Managing Abnormal PAPs in 2014 Session Description: Linda Eckert, MD Review current guidelines
More informationOutcome of Atypical Squamous Cells in Cervical Cytology: Follow-up Assessment by Loop Electrical Excision Procedure
The Korean Journal of Pathology 2012; 46: 359-364 ORIGINAL ARTICLE Outcome of Atypical Squamous Cells in Cervical Cytology: Follow-up Assessment by Loop Electrical Excision Procedure Joon Seon Song Ilseon
More informationColposcopy. Attila L Major, MD, PhD
Colposcopy Attila L Major, MD, PhD Histology Colposcopy Cytology It has been estimated that annual Pap smear testing reduces a woman s chance of dying of cervical cancer from 4 in 1000 to about 5 in 10,000
More informationThe AutoPap Primary Screening System (APSS; Tripath Imaging,
CANCER CYTOPATHOLOGY 129 A Feasibility Study of the Use of the AutoPap Screening System as a Primary Screening and Location-Guided Rescreening Device Massimo Confortini, M.D. 1 Lucia Bonardi, M.D. 1 Paolo
More informationDiagnostics: The Effect on Evidence Based Clinical Pathways. DNA vs Disease. Bruce K. Pa+erson MD CEO and President, IncellDx, Inc.
Diagnostics: The Effect on Evidence Based Clinical Pathways DNA vs Disease Bruce K. Pa+erson MD CEO and President, IncellDx, Inc. Who Who are we? We Are Cancer First platform to combine proteomic and genomic
More informationHuman Papillomavirus Testing in Head and Neck Carcinomas
Human Papillomavirus Testing in Head and Neck Carcinomas Guideline from the College of American Pathologists Early Online Release Publication: Archives of Pathology & Laboratory Medicine 12/18/2017 Overview
More informationCAP Laboratory Improvement Programs
CAP Laboratory Improvement Programs Practices of Participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology, 2006 Galen M. Eversole, MD; Ann T. Moriarty,
More informationGlandular lesions in cervical cytology. Margareta Strojan Fležar Institute of Pathology Faculty of Medicine University of Ljubljana Slovenia
Glandular lesions in cervical cytology Margareta Strojan Fležar Institute of Pathology Faculty of Medicine University of Ljubljana Slovenia 2nd PANNONIA CONGRESS OF PATHOLOGY, SIÓFOK, HUNGARY, 17-19 MAY
More informationCan LBC Completely Replace Conventional Pap Smear in Developing Countries
The Journal of Obstetrics and Gynecology of India (January February 2019) 69(1):69 76 https://doi.org/10.1007/s13224-018-1-7 ORIGINAL ARTICLE Can LBC Completely Replace Conventional Pap Smear in Developing
More informationComparison of Diagnostic Cytomorphology of Atypical Squamous Cells in Liquid-Based Preparations and Conventional Smears
The Korean Journal of Pathology 2012; 46: 365-369 ORIGINAL ARTICLE Comparison of Diagnostic Cytomorphology of Atypical Squamous Cells in Liquid-Based Preparations and Conventional Smears Jung Dal Lee 1,2
More informationMaking Sense of Cervical Cancer Screening
Making Sense of Cervical Cancer Screening New Guidelines published November 2012 Tammie Koehler DO, FACOG The incidence of cervical cancer in the US has decreased more than 50% in the past 30 years because
More informationThyroid Nodules: Understanding FNA Cytology (The Bethesda System for Reporting of Thyroid Cytopathology) Shamlal Mangray, MB, BS
Thyroid Nodules: Understanding FNA Cytology (The Bethesda System for Reporting of Thyroid Cytopathology) Shamlal Mangray, MB, BS Attending Pathologist Rhode Island Hospital, Providence, RI DISCLOSURE:
More informationDysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.
CLINICAL PRACTICE GUIDELINE Guideline Number: DHMP_DHMC_PG1015 Guideline Subject: Routine Cervical Cancer Screening Effective Date: 9/2018 Revision Date: 9/2019 Pages: 2 of 2 Quality Management Committee
More informationCINtec PLUS and the Pap smear: a co-testing alternative
CINtec PLUS and the Pap smear: a co-testing alternative Rosemary Tambouret MD p16/ki67 (CINtec PLUS) and the Pap smear Rosemary Tambouret MD CINtec PLUS dual stain: p16 and Ki67 p16 is anti-proliferative
More informationCytomorphologic Features According to HPV DNA Type in Histologically Proven Cases of the Uterine Cervix
The Korean Journal of Pathology 2011; 45: 612-620 http://dx.doi.org/10.4132/koreanjpathol.2011.45.6.612 Cytomorphologic Features According to HPV DNA Type in Histologically Proven Cases of the Uterine
More informationUse and Abuse of Onsite Adequacy for EUS-FNA of the Pancreas
Use and Abuse of Onsite Adequacy for EUS-FNA of the Pancreas Nirag Jhala MD Director of Cytopathology Perelman Center for Advanced Medicine Surgical Pathologist- GI Subspecialty Dept of Path and Lab Medicine
More informationI have no financial interests to disclose.
Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics I have no financial interests
More informationQUALITY ASSURANCE PROGRAM CYTOLOGY CYCLE 01/2018 (TRIAL)
[Pick the Date] FINAL REPORT QUALITY ASSURANCE PROGRAM CYTOLOGY CYCLE 01/2018 (TRIAL) NOTES FROM THE COORDINATOR 1. For this cycle 01/2018, a total of 32 pen drives had been circulated. Twenty-eight institutions
More informationCan HPV-16 Genotyping Provide a Benchmark for Cervical Biopsy Specimen Interpretation?
Anatomic Pathology / Monitoring HPV-16 Fractions in CIN Can HPV-16 Genotyping Provide a Benchmark for Cervical Biopsy Specimen Interpretation? Mary T. Galgano, MD, 1 Philip E. Castle, PhD, MPH, 2 Mark
More informationThe Bethesda System: Updates for th Cytopathology Congress Bursa, Turkey October 14, 2015
HARVARD MEDICAL SCHOOL The Bethesda System: Updates for 2015 6th Cytopathology Congress Bursa, Turkey October 14, 2015 David C. Wilbur, M.D. Dept. of Pathology Massachusetts General Hospital DISCLOSURES
More informationThe LAST Guidelines in Clinical Practice. Implementing Recommendations for p16 Use
AJCP / Original Article The LAST Guidelines in Clinical Practice Implementing Recommendations for p16 Use Lani K. Clinton, MD, PhD, 1,2 Kyle Miyazaki, 1 Asia Ayabe, 1 James Davis, PhD, 2 Pamela Tauchi-Nishi,
More informationUtility of Pap Smear in Cervical Screening in a Tertiary Care Hospital
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 1 (2017) pp. 319-323 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2017.601.039
More informationAwatif Al-Nafussi, Gemma Rebello, Raja Al-Yusif, Euphemia McGoogan
J Clin Pathol 2000;53:439 444 439 Papers Department of Pathology, Medical School, Teviot Place, Edinburgh EH8 9AG, UK A Al-Nafussi G Rebello R Al-Yusif E McGoogan Correspondence to: Dr Al-Nafussi email:
More informationMorphologic Clues and Pitfalls for High Grade Lesions in Cervical Cytology
Morphologic Clues and Pitfalls for High Grade Lesions in Cervical Cytology Ritu Nayar, MD Northwestern University, Feinberg School of Medicine Chicago, IL, USA Disclosures Editor, Cervical Cytology Bethesda
More informationCytopathology. Robert M Genta Pathologie Clinique Université de Genève
Cytopathology Robert M Genta Pathologie Clinique Université de Genève Learning objectives At the end of this hour you will know: 1. What cytopathology is 2. How specimens are collected, processed, and
More information3/24/2017. Disclosure of Relevant Financial Relationships. Mixed Epithelial Endometrial Carcinoma. ISGyP Endometrial Cancer Project
Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to influence or control the content of CME disclose any relevant financial relationship
More informationCytopathology Education and Technology Consortium
American Society of Cytopathology Executive Board Meeting AGENDA May 3, 2010, 7:30 AM 4:00 PM, Central Valencia Room Intercontinental Hotel Chicago, Illinois Cytopathology Education and Technology Consortium
More informationPushing the Boundaries of the Lab Diagnosis in Asia
Pushing the Boundaries of the Lab Diagnosis in Asia Diana Lim MBBS, FRCPA, FRCPath (UK) Senior Consultant National University Health System and National University of Singapore Department of Pathology
More informationGynecologic Cytopathology: Glandular lesions
Gynecologic Cytopathology: Glandular lesions Lin Wai Fung (MSc, MPH, CMIAC) 17/4/2014 Glandular lesions of the uterus Endocervix Endometrium Normal endocervical cells Sheets, strips well-preserved architecture:
More informationNegative Colposcopic Biopsy After Positive Human Papilloma Virus (HPV) DNA Testing False-Positive HPV Results or False-Negative Histologic Findings?
Anatomic Pathology / FALSE-NEGATIVE HISTOLOGIC FINDINGS Negative Colposcopic Biopsy After Positive Human Papilloma Virus (HPV) DNA Testing False-Positive HPV Results or False-Negative Histologic Findings?
More informationToyonori Tsuzuki MD, PhD Professor and Chair Department of Surgical Pathology Aichi Medical University Hospital
29th European Congress of Pathology (ECP 2017) Amsterdam RAI. The Paris System for Reporting Urinary Cytology: The Concept and Management Toyonori Tsuzuki MD, PhD Professor and Chair Aichi Medical University
More informationJanuary 15, 2009 (202) PROPOSALS TO IMPROVE CYTOLOGY PROFICIENCY TESTING REQUIRED BY THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS OF 1988
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services Room 352-G 200 Independence Avenue, SW Washington, DC 20201 Office of Media Affairs CMS FACT SHEET FOR IMMEDIATE RELEASE Contact:
More informationManagement of Abnormal Cervical Cytology and Histology
Management of Abnormal Cervical Cytology and Histology Assoc. Prof. Gökhan Tulunay Etlik Zübeyde Hanım Women s Diseases Teaching & Research Hospital Gynecologic Oncology Clinic Universally accepted guideline
More informationStudy Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationCervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH
Cervical Testing and Results Management An Evidenced-Based Approach April 22nd, 2010 Debora Bear, MSN, MPH Assistant Medical Director for Planned Parenthood of New Mexico, Inc. Burden of cervical cancer
More informationThinPrep 5000 Processor Instructions for Use
5000 Processor Instructions for Use MAN-04008-001 Rev. 001 Page 1 of 27 INTENDED USE The 5000 processor is intended as a replacement for the conventional method of Pap smear preparation for use in screening
More informationPancreatic malignant tumors are the fifth leading cause of cancerrelated
44 CANCER CYTOPATHOLOGY Cytologic Criteria for Well Differentiated Adenocarcinoma of the Pancreas in Fine-Needle Aspiration Biopsy Specimens Fan Lin, M.D., Ph.D. 1 Gregg Staerkel, M.D. 2 1 Department of
More informationCervical Cancer : Pap smear
Taking a PAP SMEAR Cervical Cancer : Pap smear George N Papanicolaou introduced cervical cytology in clinical practice in 1940 In 1945, PAP smear was endorsed by American cancer society as an effective
More informationScreening for the Precursors of Cervical Cancer in the Era of HPV Vaccination. Dr Stella Heley Senior Liaison Physician Victorian Cytology Service
Screening for the Precursors of Cervical Cancer in the Era of HPV Vaccination Dr Stella Heley Senior Liaison Physician Victorian Cytology Service Victorian Cytology Service Dr Stella Heley Dr Siobhan Bourke
More informationAppropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines
Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates
More informationComparison of Cytologic Characteristics between Adenoid Cystic Carcinoma and Adenoid Basal Carcinoma in the Uterine Cervix
Journal of Pathology and Translational Medicine 2015; 49: 396-402 ORIGINAL ARTICLE Comparison of Cytologic Characteristics between Adenoid Cystic Carcinoma and Adenoid Basal Carcinoma in the Uterine Cervix
More informationStandards for Pathology Informatics in Australia (SPIA)
Standards for Pathology Informatics in Australia (SPIA) Reporting Terminology and Codes Cytopathology (v3.0) Superseding and incorporating the Australian Pathology Units and Terminology Standards and Guidelines
More informationEBUS-TBNA Diagnosis and Staging of Lung Cancer
EBUS-TBNA Diagnosis and Staging of Lung Cancer Nirag Jhala MD, MIAC Professor of Pathology and Lab Med. Director of Anatomic Pathology and Cytopathology Lewis Katz School of Medicine@ Temple University
More informationDr. Issraa Ali Hussein
CLINICAL 09888888;rCYTOLOGY Dr. Issraa Ali Hussein objectives Define diagnostic cytology (clinical cytology). Explain the differences between histopathology and cytopathology. Recognize the methods for
More informationGynecologic Cytology-Histology Correlation Guideline
Gynecologic Cytology- Correlation Guideline George G. Birdsong, MD and Joe W. Walker, Jr., MS, SCT(ASCP) CM Clinical Practice Committee Dr. Birdsong and Mr. Walker are grateful for extensive input from
More informationBecoming a colposcopist: Colposcope case studies
Becoming a colposcopist: Colposcope case studies Seon-Kyung Lee, M.D. Department of Obstetrics and Gynecology College of Medicine, Kyung Hee University Value of Colposcopy Cytology is an effective screening
More informationEffect of human papillomavirus vaccination on cervical cancer screening in Alberta
Effect of human papillomavirus vaccination on cervical cancer screening in Alberta Presenter: Jong Kim 1 Team: Christopher Bell 2, Maggie Sun 3, Gordon Kliewer 3, Linan Xu 3, Maria McInerney 4, Lawrence
More informationGranular lymphoblast in a case of acute lymphoblastic leukemia: A rare morphology
www.edoriumjournals.com CLINICAL IMAGES PEER REVIEWED OPEN ACCESS Granular lymphoblast in a case of acute lymphoblastic leukemia: A rare morphology Shehab Fareed Mohamed, Dina Sameh Soliman, Firyal Ibrahim
More informationA Study on Diagnostic Accuracy of Cervical Pap Smear by Correlating with Histopathology in a Tertiary Care Centre
Original Article DOI: 10.21276/APALM.1878 A Study on Diagnostic Accuracy of Cervical Pap Smear by Correlating with Histopathology in a Tertiary Care Centre Rachana L Y, S.S. Hiremath*, Prabhu M H, S.S
More informationEradicating Mortality from Cervical Cancer
Eradicating Mortality from Cervical Cancer Michelle Berlin, MD, MPH Vice Chair, Obstetrics & Gynecology Associate Director, Center for Women s Health June 2, 2009 Overview Prevention Human Papilloma Virus
More informationFaculty Pap Smear Guidelines: Family Planning Update 2008 Part Two
Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Seshu P. Sarma, MD, FAAP Emory University Regional Training Center Atlanta, Georgia Produced by the Alabama Department of Public Health
More informationCervical Screening for Dysplasia and Cancer in Patients with HIV
Cervical Screening for Dysplasia and Cancer in Patients with HIV Adult Clinical Guideline from the New York State Department of Health AIDS Institute w w w.hivg uidelines.org Purpose of the Guideline Increase
More informationAn audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia
DOI:10.1111/j.1365-2303.2009.00695.x An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia S. A. Thiryayi, J. Marshall and D. N. Rana Manchester
More informationAssociate Professor of Gyn. & Obs., Department of Gynecology and Obstetrics, Tehran University of Medical Sciences, Iran.
Assessment of Visual Inspection with Acetic Acid (VIA) as a Screening Test for Cervical Neoplasia in Comparison with Cytologic Screening in Imam Khomeini Hospital F. Ghaemmaghami, MD Associate Professor
More informationInterpretation guide. Abnormal cytology can t hide anymore
Interpretation guide Abnormal cytology can t hide anymore Unique dual-biomarker technology makes you certain about the presence of transforming HPV infection. The science that creates certainty. Table
More information